Vitamin C: The next step in sepsis management?

被引:49
作者
Teng, J. [1 ]
Pourmand, A. [1 ]
Mazer-Amirshahi, M. [2 ,3 ]
机构
[1] George Washington Univ, Sch Med & Hlth Sci, Emergency Med Dept, Washington, DC 20037 USA
[2] MedStar Washington Hosp Ctr, Dept Emergency Med, Washington, DC USA
[3] Georgetown Univ, Sch Med, Washington, DC USA
关键词
Sepsis; Septic shock; Vitamin C; Ascorbic acid; Ascorbate; ASCORBIC-ACID; ENDOTHELIAL-CELLS; VASOPRESSIN; MODULATION; MECHANISMS; EXPRESSION; FAILURE; PLASMA; SHOCK;
D O I
10.1016/j.jcrc.2017.09.031
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Sepsis is a life-threateningmedical condition, affecting approximately 26million peopleworldwide every year. The disease is a continuum, marked by dysregulated inflammation and hemodynamic instability leading to shock, multi-system organ dysfunction, and death. Over the past decades, there has been a focus on the early identification and treatment of sepsis primarilywith bundled and goal directed therapy. Despite these advances, morbidity and mortality has remained high, prompting investigation into novel therapies. Vitamin C is a water-soluble vitamin that plays a role inmediating inflammation through antioxidant activities and is also important in the synthesis of cortisol, catecholamines, and vasopressin, which are keymediators in the disease process. Emerging evidence provides cursory data in support of the administration of vitamin C in addition to standard therapy to ameliorate the effects of inflammation and improve hemodynamic stability in patients with sepsis and septic shock; however, further evidence is needed to support this practice. This review discusses the physiologic role of vitamin C as well as the recent literature and evidence for the use of vitamin C in patients presenting with sepsis. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 40 条
[31]   Therapeutic Targets in Sepsis: Past, Present, and Future [J].
Seeley, Eric J. ;
Bernard, Gordon R. .
CLINICS IN CHEST MEDICINE, 2016, 37 (02) :181-189
[32]   Depletion of neurohypophyseal content of vasopressin in septic shock [J].
Sharshar, T ;
Carlier, R ;
Blanchard, A ;
Feydy, A ;
Gray, F ;
Paillard, M ;
Raphael, JC ;
Gajdos, P ;
Annane, D .
CRITICAL CARE MEDICINE, 2002, 30 (03) :497-500
[33]   Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration - A randomized, prospective study [J].
Tanaka, H ;
Matsuda, T ;
Miyagantani, Y ;
Yukioka, T ;
Matsuda, H ;
Shimazaki, S .
ARCHIVES OF SURGERY, 2000, 135 (03) :326-331
[34]   PLASMA NUCLEAR AND MITOCHONDRIAL DNA LEVELS, AND MARKERS OF INFLAMMATION, SHOCK, AND ORGAN DAMAGE IN PATIENTS WITH SEPTIC SHOCK [J].
Timmermans, Kim ;
Kox, Matthijs ;
Scheffer, Gert Jan ;
Pickkers, Peter .
SHOCK, 2016, 45 (06) :607-612
[35]   The vasopressin system - Physiology and clinical strategies [J].
Treschan, Tanja A. ;
Peters, Juergen .
ANESTHESIOLOGY, 2006, 105 (03) :599-612
[36]   Is worsening multiple organ failure the cause of death in patients with severe sepsis? [J].
Vincent, Jean-Louis ;
Nelson, David R. ;
Williams, Mark D. .
CRITICAL CARE MEDICINE, 2011, 39 (05) :1050-1055
[37]   Evaluation of Vitamin C for Adjuvant Sepsis Therapy [J].
Wilson, John X. .
ANTIOXIDANTS & REDOX SIGNALING, 2013, 19 (17) :2129-2140
[38]   Mechanism of action of vitamin C in sepsis: Ascorbate modulates redox signaling in endothelium [J].
Wilson, John X. .
BIOFACTORS, 2009, 35 (01) :5-13
[39]  
Yawalkar V, 2016, J ASSOC PHYSICIAN I, V64, P120
[40]   Effect of high-dose Ascorbic acid on vasopressor's requirement in septic shock [J].
Zabet, Mohadeseh Hosseini ;
Mohammadi, Mostafa ;
Ramezani, Masoud ;
Khalili, Hossein .
JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2016, 5 (02) :94-100